Hormonal contraception
174 results
27 - 126
Hormonal contraception 
Risk of fracture in users of hormonal contraception- Hormonal contraception for women at risk of HIV infection.
Modern hormonal contraception associated with increased risk of breast cancer- Hormonal contraception for women exposed to HIV infection: Cochrane systematic review
- Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
- Immediate start of hormonal contraceptives for contraception
- Hormonal contraceptives for contraception in overweight or obese women
- Repeated use of pre‐ and postcoital hormonal contraception for prevention of pregnancy
- Risk of ischaemic stroke in persons with migraine without aura using combined hormonal contraception
- Combined hormonal versus nonhormonal versus progestin‐only contraception in lactation
- Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception: Cochrane systematic review
- Hormonal and intrauterine methods for contraception for women aged 25 years and younger
- Women who use levonorgestrel-releasing intrauterine devices are less likely to develop ischemic stroke than nonusers of hormonal contraception
- Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception
- Contraception in patients with systemic diseases
- Contraception: initiation, choice of method and follow-up
- Postcoital contraception
- Certain hormonal contraceptives increase thromboembolism risk when taken with NSAIDs
- Copper containing intra‐uterine devices versus depot progestogens for contraception
- Low incidence of pregnancy with same-day-start contraception
- Acne
- Interventions to improve contraception use
- 20 mcg versus over 20 mcg estrogen combined oral contraceptives for contraception
- Skin patch and vaginal ring versus combined oral contraceptives for contraception
- Steroid hormones for contraception in women with sickle cell disease
- High continuation of contraceptive ring vs patch
- Risk of ischaemic stroke in people with migraine with aura
- Steroid hormones for contraception in men: Cochrane systematic review
- Overweight in pregnancy
- Oral contraceptives increase risk of thrombotic stroke and MI
- Combined hormonal contraceptives for heavy menstrual bleeding
- Combined oral contraceptives and bone mineral density
- Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
- Risk of venous thromboembolism in users of combined contraceptives
- Fertility returns within 6 months for more than 50% of the women who stop using contraceptives
- Ischaemic stroke and myocardial infarction risk with combined oral contraceptives
- Risk of venous thrombosis in users of 3rd vs. 2nd generation combined oral contraceptives
- Combined oral contraceptives for heavy menstrual bleeding
- Oral contraceptives in the treatment of endometriosis
- Oral contraceptives and the risk of ovarian cancer
- Levonorgestrel is ineffective emergency contraception for obese women
- Progestins for symptomatic treatment of endometriosis
- Sterilization
- Abnormal menstrual bleeding
- Intrauterine device
- Dysmenorrhoea
- Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception.
- Progestogen‐releasing intrauterine systems versus other forms of reversible contraceptives for contraception
- Combination contraceptives: effects on weight
- Progestin intrauterine devices versus copper intrauterine devices for emergency contraception
- Secondary hypertension
- Continuous or extended cycle use of combined oral contraceptives
- Oestrogens and progestins for preventing and treating postpartum depression: Cochrane systematic review
- Behavioral interventions for improving dual-method contraceptive use: Cochrane systematic review
- Skin problems in people with dark skin